Young Li
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Initiates: Buy | $72 | $51.10 | +40.90% | 1 | Oct 29, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $105.85 | +8.64% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $0.98 | +27.55% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $42.43 | +41.41% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $16.53 | +178.28% | 1 | Jul 16, 2021 |
RxSight
Oct 29, 2024
Initiates: Buy
Price Target: $72
Current: $51.10
Upside: +40.90%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $105.85
Upside: +8.64%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $0.98
Upside: +27.55%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $42.43
Upside: +41.41%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $16.53
Upside: +178.28%